$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
AIM ImmunoTech Announces Closing of its Rights Offering
07:00pm, Friday, 06'th Mar 2026
OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
02:48am, Wednesday, 04'th Mar 2026
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy
Nike Circuit Goes Next Gen: Bringing AIM Sports Group's AIM+ Platform to All Youth Volleyball Events
12:25pm, Tuesday, 03'rd Mar 2026
CLEVELAND--(BUSINESS WIRE)-- #AIM--The Nike Circuit, a leading national boys and girls volleyball event operator, has announced AIM Sports Group as its exclusive digital partner, and will continue to
Buccaneer Energy seals funding as it looks to boost oil production
10:57am, Monday, 02'nd Mar 2026
Buccaneer Energy Plc (AIM:BUCE, FRA:LMU1) confirmed to investors it has closed a £350,000 fundraise to finance an adjacent producing-well acquisition in East Texas and push ahead with an Organic Oi
OCALA, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced an agreement with the PPD™ clinical research business of Th
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
09:00am, Friday, 27'th Feb 2026
OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and d
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
02:30am, Thursday, 26'th Feb 2026
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed biotechn
OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced milestones in the expected timeline for the ongoing Phase 2 cl
TomCo Energy agrees new Valkor deal and raises some working capital, shares drop
05:06am, Monday, 23'rd Feb 2026
TomCo Energy PLC (AIM:TOM, OTC:TMCGF) shares dropped 35% on Monday, falling to 0.035p, impacted by expected new equity dilution, after it announced a renewed partnership with Valkor LLC that leaves
Rome Resources unearths "exciting new areas" for tin and copper at Mont Agoma
03:28am, Thursday, 19'th Feb 2026
Rome Resources Plc (AIM:RMR, FRA:33R) has sharpened drill targeting at its Mont Agoma prospect in the Democratic Republic of Congo after a new geological interpretation outlined fresh, high-priority z
Seeing Machines flags second-half profit as EU car safety deadline nears
02:51am, Wednesday, 18'th Feb 2026
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z), the AIM-listed computer vision technology company, said it expected automotive production volumes to “increase materially” in the coming quarters
Falcon Oil & Gas Ltd. - Notice of Cancellation of Admission to Trading on AIM
02:00am, Tuesday, 17'th Feb 2026
Falcon Oil & Gas Ltd. (“Falcon”) Notice of Cancellation of Admission to Trading on AIM 17 February 2026 - Falcon Oil & Gas Ltd.
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
04:35pm, Thursday, 12'th Feb 2026
This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on Fe
AIM ImmunoTech Announces Commencement of Rights Offering
08:30am, Wednesday, 11'th Feb 2026
OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and d
Aimia Inc. (AIM:CA) M&A Call Transcript
12:14pm, Monday, 09'th Feb 2026
Aimia Inc. (AIM:CA) M&A Call Transcript
Sign In
Buy AIM